Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening

doi:10.3748/wjg.v22.i12.3460

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6761)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

544

WORD

247

HTML

3211

Figures (1-3)

157

Tables (1-2)

145

Sum=4304

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

1570

Sum=2457

Mar 28, 2016 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine

World J Gastroenterol. Mar 28, 2016; 22(12): 3460-3470
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3460

Table 2 Simulated results for screening strategies to prevent hepatocellular carcinoma

Outcome	No intervention	Two-stage screening	Mass screening using ultrasonography
Cost per individual screened, USD	2755	3389	3359
Life-year gain¹ (yr)	20.4798	20.4926	20.4950
Comparing with ICER
No screening as reference	-	49733	39825
Two-stage screening as reference	-	-	Dominant²

¹Screening starting age was 40 years old, screening interval was 1 year;

²More effective and less costly than reference strategy. ICER: Incremental cost-effectiveness ratio.

Citation: Kuo MJ, Chen HH, Chen CL, Fann JCY, Chen SLS, Chiu SYH, Lin YM, Liao CS, Chang HC, Lin YS, Yen AMF. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening. World J Gastroenterol 2016; 22(12): 3460-3470
URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3460.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3460